Sree Rayalaseema Hi-Strength Hypo financials

·ChemicalsChart ›
Latest results Q1 FY27 · Apr–Jun 2026
Revenue
₹211cr+17.0% on Q1 FY26
Net profit
₹24.7cr+10.3% on Q1 FY26
EBITDA margin
14.2%−1.3 pts on Q1 FY26
EPS
₹14.53+11.3% on Q1 FY26

Quarterly results

Every quarter ›
₹ croreQ1 FY27Q1 FY26Change
Revenue211180+17.0%
EBITDA29.927.9+6.9%
EBITDA margin14.2%15.5%−1.3 pts
Profit before tax33.931.3+8.2%
Net profit24.722.4+10.3%
EPS₹14.53₹13.06+11.3%

Over time

Q1 FY27 · Apr–Jun 2026latest
Revenue₹211 crNet profit₹24.7 crNet margin11.7%

Amounts on the left scale in ₹ crore; per cent on the right, dashed. L = lakh crore, K = thousand crore. Touch the chart to read any period.

Key numbersby financial year

₹ crore except per share
Tap a line for its trendCurrentlast 12MFY26Mar 2026FY25Mar 2025FY24Mar 2024FY23Mar 2023FY22 and earlierAlpha Plus
857————
FY22 and earlierEvery year the company has filed comes with Alpha Plus.
43443436915.126.8
13.213.214.50.10.2
0.40.414.48.011.9
436————
6986676388661,650
—+4.6%−26.3%−47.5%—
90.488.592.0111178
13.0%13.3%14.4%12.8%10.8%
83.281.284.7100.0158
91.890.187.579.0154
13.2%13.5%13.7%9.1%9.4%
₹53.50₹52.52₹50.96₹46.01₹89.87
—+3.1%+10.8%−48.8%—
—39.265.2139141
—−6.3−2.4−20.0−9.9
32.832.862.8119132
Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

SRHHYPOLTD₹499.15

Sree Rayalaseema Hi-Strength Hypo Limited

· Chemicals
₹ CrorePeersGEMAROMADMCCSUDARCOLORJAYAGROGNKRONOXAMNPLSTCHEMFABPRIMOMcap ₹857 Cr
HighlightsEnterprise ValueMultiplesPer ShareAnnuals · FY-end closes
In ₹ Crore except Per Share
12 Months Ending
FY23
31/03/2023
FY24
31/03/2024
FY25
31/03/2025
FY26
31/03/2026
Current/LTM
TTM · last close
Market Capitalization————856.8
- Cash, Equiv & ST Investments26.815.1369.0434.2434.2
+ Minority Interest0.20.114.513.213.2
+ Total Debt11.98.014.40.40.4
Enterprise Value————436.2
Revenue1,650.1866.0637.8667.0697.6
Growth %, YoY—-47.5-26.3+4.6—
EBITDA177.7110.692.088.590.4
Margin %10.7712.7714.4313.2612.96
EBIT158.3100.084.781.283.2
Net Income154.379.087.590.191.8
Margin %9.359.1213.7113.5213.16
EPS, Adj (current shares)89.8746.0150.9652.5253.50
Growth %, YoY—-48.8+10.8+3.1—
Cash from Operations141.4138.665.239.2—
Capital Expenditures-9.9-20.0-2.4-6.3—
Free Cash Flow131.5118.662.832.832.8
Market Cap/EV/multiples pair each (split/bonus-adjusted) FY-end close with the latest filed share count; Current column uses the last close. Market Capitalization is a market-level figure — identical across Consolidated/Standalone (the accounting rows below differ). No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.

Sree Rayalaseema Hi-Strength Hypo financials and key ratios

Prices at the previous close · figures from the company's filings with NSE

Sree Rayalaseema Hi-Strength Hypo (NSE: SRHHYPOLTD) had a market capitalisation of ₹857 crore at the previous close (₹499.15 a share), a PE ratio of 9.3 on the last four quarters' profit and a price-to-book ratio of 0.88. In FY26 its consolidated net profit was ₹90.1 crore on revenue of ₹667 crore; in Q1 FY27 (April–June 2026) it was ₹25 crore, up 11.4% year on year. Its debt-to-equity ratio was 0.00 on 31 March 2026. Promoters held 62.19% of the shares on 30 September 2026.

Share price used
₹499.15 · previous close
Latest balance sheet
31 March 2026
Shareholding pattern
30 September 2026

Sree Rayalaseema Hi-Strength Hypo at a glance · consolidated

Market cap
₹857 Crat ₹499.15 · previous close
PE ratio (last 4 quarters)
9.39.5 on FY26 profit
Price to book (PB)
0.88book value ₹565.76 a share
ROE (FY26)
9.5%−0.6 pts vs FY25ROCE 7.9%
Debt to equity
0.00net cash ₹438 Cr
Promoter holding
62.19%+0.3 pts vs 30 Jun 202630 September 2026
Dividend yield
0.60%₹3 a share in 12 months
Net worth
₹971 Cr+5.6% vs 31 Mar 202531 March 2026
Free cash flow (FY26)
₹32.8 Cr−47.7% vs FY25

Questions

What is the Sree Rayalaseema Hi-Strength Hypo PE ratio today?

Sree Rayalaseema Hi-Strength Hypo's PE ratio is 9.3 at the previous close (₹499.15 a share): a market capitalisation of ₹857 crore divided by consolidated net profit of ₹92.1 crore over the last four quarters (Q2 FY26 to Q1 FY27). On FY26 net profit (₹90.1 crore) it is 9.5.

Is Sree Rayalaseema Hi-Strength Hypo debt free?

No. Sree Rayalaseema Hi-Strength Hypo had borrowings of ₹39 lakh on 31 March 2026 (consolidated balance sheet), a debt-to-equity ratio of 0.00. Its cash and current investments were ₹439 crore, so it held net cash of ₹438 crore.

What is the Sree Rayalaseema Hi-Strength Hypo book value per share?

Sree Rayalaseema Hi-Strength Hypo's book value per share was ₹565.76 on 31 March 2026: shareholders' equity of ₹971 crore divided by the 1.72 crore shares in issue, up 5.6% from ₹535.72 a year earlier. The share price at the previous close was ₹499.15.

What is the Sree Rayalaseema Hi-Strength Hypo PB ratio (price to book value)?

Sree Rayalaseema Hi-Strength Hypo's price-to-book (PB) ratio is 0.88 at the previous close: a market capitalisation of ₹857 crore divided by shareholders' equity (book value) of ₹971 crore on 31 March 2026. That is a book value of ₹565.76 per share against a share price of ₹499.15.

What is the Sree Rayalaseema Hi-Strength Hypo net worth?

Sree Rayalaseema Hi-Strength Hypo's net worth — shareholders' equity in its consolidated balance sheet — was ₹971 crore on 31 March 2026, up 5.6% from ₹920 crore a year earlier. Its market value is a different figure: a market capitalisation of ₹857 crore at the previous close.

What is the Sree Rayalaseema Hi-Strength Hypo ROE and ROCE?

In FY26, Sree Rayalaseema Hi-Strength Hypo's return on equity (ROE) was 9.5% and its return on capital employed (ROCE) was 7.9%. ROE is net profit divided by average shareholders' equity (the start and end of the year); ROCE is operating profit (EBIT) divided by average capital employed (total assets less current liabilities). In FY25, ROE was 10.2% and ROCE 9.1%.

What is the Sree Rayalaseema Hi-Strength Hypo market cap?

Sree Rayalaseema Hi-Strength Hypo's market capitalisation was ₹857 crore at the previous close: 1.72 crore shares at ₹499.15 each.

What is the Sree Rayalaseema Hi-Strength Hypo debt to equity ratio?

Sree Rayalaseema Hi-Strength Hypo's debt-to-equity ratio was 0.00 on 31 March 2026: borrowings of ₹39 lakh against total equity of ₹984 crore. A year earlier, on 31 March 2025, it was 0.02.

What is the Sree Rayalaseema Hi-Strength Hypo EPS?

Sree Rayalaseema Hi-Strength Hypo's basic earnings per share (EPS) were ₹53.24 in FY26, against ₹50.96 in FY25. Over the last four quarters (Q2 FY26 to Q1 FY27) they add up to ₹54.09.

What is the Sree Rayalaseema Hi-Strength Hypo dividend yield?

Sree Rayalaseema Hi-Strength Hypo's dividend yield is 0.60% at the previous close: dividends of ₹3 a share that went ex-dividend in the 12 months before that day, divided by the share price of ₹499.15. They were ₹3 on 18 September 2026.

What is the Sree Rayalaseema Hi-Strength Hypo promoter holding?

Promoters held 62.19% of Sree Rayalaseema Hi-Strength Hypo on 30 September 2026, up 0.35 percentage points from 61.84% the previous quarter and up 0.35 percentage points from 61.84% a year earlier, according to the shareholding pattern filed with NSE.

What is the Sree Rayalaseema Hi-Strength Hypo free cash flow?

In FY26, Sree Rayalaseema Hi-Strength Hypo generated ₹39.2 crore of cash from operations and spent ₹6.3 crore on capital expenditure (property, plant, equipment and intangibles), leaving free cash flow of ₹32.8 crore. In FY25 it was ₹62.8 crore.

What is the Sree Rayalaseema Hi-Strength Hypo dividend in 2026 and its record date?

In 2026, Sree Rayalaseema Hi-Strength Hypo has declared one dividend: ₹3 with record date 18 September 2026.

What are the Sree Rayalaseema Hi-Strength Hypo latest quarterly results?

Sree Rayalaseema Hi-Strength Hypo's latest results are for Q1 FY27 (April–June 2026), filed on 12 August 2026: consolidated net profit ₹25 crore, up 11.4% from ₹22.4 crore in Q1 FY26; revenue from operations ₹211 crore, up 17.0% year on year.

When are the Sree Rayalaseema Hi-Strength Hypo next results?

Sree Rayalaseema Hi-Strength Hypo has not yet announced the date of its Q2 FY27 results (July–September 2026); under SEBI's listing rules (Regulation 33) they are due by 14 November 2026.

What is the Sree Rayalaseema Hi-Strength Hypo shareholding pattern?

On 30 September 2026, Sree Rayalaseema Hi-Strength Hypo's shares were held by promoters 62.19%, foreign portfolio investors (FII/FPI) 0.30%, domestic institutions (DII) 0.05% (including mutual funds at 0.01%) and retail and other non-institutional investors 37.47%. Over the year, FII holding was up 0.24 percentage points from 0.06% and DII holding was unchanged.

What is the Sree Rayalaseema Hi-Strength Hypo revenue and profit in FY26?

In FY26 (April 2025–March 2026), Sree Rayalaseema Hi-Strength Hypo's consolidated net profit was ₹90.1 crore, up 3.1% from ₹87.5 crore in FY25, on revenue from operations of ₹667 crore (up 4.6%). Over three years, from FY23, net profit was down 41.6%.

Sree Rayalaseema Hi-Strength Hypo vs Gem Aromatics: how do they compare?

In FY26, Sree Rayalaseema Hi-Strength Hypo earned net profit of ₹90.1 crore on revenue of ₹667 crore, against ₹1.4 crore on ₹366 crore for Gem Aromatics. Sree Rayalaseema Hi-Strength Hypo's operating margin was 12.2% (Gem Aromatics 5.0%) and its return on equity 9.5% (Gem Aromatics 0.3%).

How does Sree Rayalaseema Hi-Strength Hypo compare with its peers?

On FY26 consolidated figures, against Gem Aromatics, DMCC SPECIALITY CHEMICALS and Sudarshan Colorants India: Sree Rayalaseema Hi-Strength Hypo's operating margin of 12.2% is the highest of the four (Gem Aromatics 5.0%, DMCC SPECIALITY CHEMICALS 8.2%, Sudarshan Colorants India 4.9%; peer average 6.0%); its return on equity of 9.5% is the second highest of the four (Gem Aromatics 0.3%, DMCC SPECIALITY CHEMICALS 11.5%, Sudarshan Colorants India 8.2%; peer average 6.7%).

Where do these Sree Rayalaseema Hi-Strength Hypo figures come from?

From Sree Rayalaseema Hi-Strength Hypo's own consolidated results, balance sheets and shareholding patterns filed with NSE. Ratios are calculated by Alphave from those filings as each answer describes.

Consolidated figures from the company's filings with NSE; prices are NSE closing prices.